X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24790) 24790
Publication (1977) 1977
Book Review (251) 251
Newsletter (84) 84
Book Chapter (59) 59
Newspaper Article (36) 36
Dissertation (21) 21
Conference Proceeding (17) 17
Magazine Article (14) 14
Book / eBook (9) 9
Transcript (8) 8
Data Set (2) 2
Government Document (1) 1
Paper (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20122) 20122
paclitaxel (13863) 13863
female (13841) 13841
index medicus (11872) 11872
oncology (11858) 11858
middle aged (9052) 9052
antineoplastic combined chemotherapy protocols - therapeutic use (8841) 8841
chemotherapy (8685) 8685
paclitaxel - administration & dosage (8623) 8623
aged (7932) 7932
cancer (7447) 7447
male (6878) 6878
adult (6739) 6739
paclitaxel - therapeutic use (5018) 5018
treatment outcome (4964) 4964
animals (4620) 4620
pharmacology & pharmacy (4204) 4204
breast neoplasms - drug therapy (3777) 3777
cisplatin (3453) 3453
lung neoplasms - drug therapy (3103) 3103
cell line, tumor (2971) 2971
antineoplastic agents - therapeutic use (2962) 2962
antineoplastic combined chemotherapy protocols - adverse effects (2925) 2925
breast cancer (2864) 2864
carboplatin - administration & dosage (2834) 2834
ovarian neoplasms - drug therapy (2804) 2804
care and treatment (2799) 2799
mice (2704) 2704
carboplatin (2653) 2653
paclitaxel - adverse effects (2651) 2651
therapy (2644) 2644
docetaxel (2628) 2628
neoplasm staging (2607) 2607
antineoplastic agents, phytogenic - therapeutic use (2585) 2585
carcinoma (2491) 2491
cisplatin - administration & dosage (2490) 2490
carcinoma, non-small-cell lung - drug therapy (2403) 2403
paclitaxel - pharmacology (2388) 2388
aged, 80 and over (2269) 2269
disease-free survival (2244) 2244
trial (2231) 2231
analysis (2211) 2211
research (2192) 2192
drug administration schedule (2183) 2183
breast neoplasms - pathology (2155) 2155
taxol (2154) 2154
ovarian cancer (2131) 2131
nanoparticles (2058) 2058
tumors (2036) 2036
drug delivery systems (1960) 1960
antineoplastic agents (1949) 1949
doxorubicin (1944) 1944
survival (1930) 1930
antineoplastic agents, phytogenic - administration & dosage (1922) 1922
survival rate (1921) 1921
apoptosis (1885) 1885
prognosis (1826) 1826
antimitotic agents (1804) 1804
deoxycytidine - analogs & derivatives (1777) 1777
medicine & public health (1770) 1770
metastasis (1715) 1715
drugs (1711) 1711
combined modality therapy (1705) 1705
drug therapy (1692) 1692
survival analysis (1666) 1666
retrospective studies (1622) 1622
health aspects (1562) 1562
combination (1554) 1554
dose-response relationship, drug (1526) 1526
gemcitabine (1525) 1525
lung neoplasms - pathology (1518) 1518
cancer therapies (1476) 1476
antineoplastic agents - administration & dosage (1451) 1451
obstetrics & gynecology (1443) 1443
paclitaxel - analogs & derivatives (1431) 1431
taxoids (1426) 1426
in-vitro (1408) 1408
ovarian neoplasms - pathology (1400) 1400
phase-ii trial (1383) 1383
neoplasms - drug therapy (1378) 1378
deoxycytidine - administration & dosage (1371) 1371
breast-cancer (1360) 1360
hematology, oncology and palliative medicine (1357) 1357
expression (1353) 1353
antineoplastic agents - pharmacology (1317) 1317
article (1307) 1307
chemotherapy, adjuvant (1300) 1300
bevacizumab (1272) 1272
clinical trials (1250) 1250
neoplasm metastasis (1250) 1250
phase-ii (1248) 1248
follow-up studies (1243) 1243
time factors (1221) 1221
drug resistance, neoplasm (1219) 1219
antineoplastic combined chemotherapy protocols - administration & dosage (1209) 1209
surgery (1186) 1186
apoptosis - drug effects (1167) 1167
taxoids - administration & dosage (1164) 1164
phase-iii trial (1139) 1139
cyclophosphamide (1127) 1127
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23703) 23703
Japanese (682) 682
Chinese (188) 188
French (147) 147
German (98) 98
Italian (38) 38
Russian (30) 30
Spanish (27) 27
Hungarian (20) 20
Polish (12) 12
Dutch (9) 9
Czech (6) 6
Portuguese (6) 6
Hebrew (5) 5
Korean (4) 4
Lithuanian (4) 4
Swedish (4) 4
Finnish (3) 3
Turkish (3) 3
Bulgarian (1) 1
Danish (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2278 - 2284
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1691 - 1703
Journal Article
Circulation, ISSN 0009-7322, 04/2011, Volume 123, Issue 16, pp. 1745 - 1756
Background-Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation... 
stents | thrombosis | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | RANDOMIZED-TRIALS | BARE-METAL STENTS | ROUTINE CLINICAL-PRACTICE | UNCOATED STENTS | CLOPIDOGREL | IMPLANTATION | LARGE 2-INSTITUTIONAL COHORT | PLATELET INHIBITION | PERIPHERAL VASCULAR DISEASE | ST-SEGMENT ELEVATION | HEMATOLOGY | DRUG-ELUTING STENTS | Recombinant Proteins - therapeutic use | Predictive Value of Tests | Myocardial Infarction - epidemiology | Coronary Thrombosis - epidemiology | Ticlopidine - therapeutic use | Hirudins | Humans | Metals | Middle Aged | Heparin - therapeutic use | Male | Angioplasty, Balloon, Coronary - statistics & numerical data | Drug-Eluting Stents - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Myocardial Infarction - therapy | Coronary Thrombosis - prevention & control | Drug-Eluting Stents - statistics & numerical data | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Antithrombins - therapeutic use | Risk Factors | Anticoagulants - therapeutic use | Coronary Restenosis - prevention & control | Treatment Outcome | Paclitaxel - therapeutic use | Ticlopidine - analogs & derivatives | Tubulin Modulators - therapeutic use | Coronary Restenosis - epidemiology | Aged | Peptide Fragments - therapeutic use | Complications and side effects | Care and treatment | Angioplasty | Research | Thrombosis | Heart attack | Stent (Surgery) | Blood clot | Risk factors
Journal Article
by Zhou, Caicun and Wu, Y.L and Chen, G and Feng, J and Liu, X.-Q and Wang, C and Zhang, S and Wang, J and Zhou, S and Ren, S and Lu, S and Zhang, L and Hu, C and Hu, C and Luo, Y and Chen, L and Ye, M and Huang, J and Zhi, X and Zhang, Y and Xiu, Q and Ma, J and Zhang, L and You, C
Annals of Oncology, ISSN 0923-7534, 09/2015, Volume 26, Issue 9, pp. 1877 - 1883
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 947 - 957
This trial compared gefitinib, an inhibitor of the tyrosine kinase of epidermal growth factor (EGFR), with carboplatin plus paclitaxel as initial treatment of... 
CELL LUNG-CANCER | RECEPTOR GENE-MUTATIONS | MEDICINE, GENERAL & INTERNAL | THERAPY | FUNCTIONAL ASSESSMENT | PROSPECTIVE PHASE-II | 1ST-LINE GEFITINIB | EGFR MUTATIONS | TREATED PATIENTS | NEVER-SMOKERS | ERLOTINIB | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Carboplatin - adverse effects | Carboplatin - therapeutic use | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Lung Neoplasms - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Paclitaxel - adverse effects | Adenocarcinoma - drug therapy | Paclitaxel - therapeutic use | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Adenocarcinoma - mortality | Care and treatment | Dosage and administration | Nonsmokers | Gefitinib | Health aspects | Lung cancer | Chemotherapy | Pharmaceutical industry | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article